Sylvia C. Kurz

Dissecting the immunosuppressive tumor microenvironments in Glioblastoma-on-a-Chip for optimized PD-1 immunotherapy

Xin Cui, Chao Ma, Varshini Vasudevaraja et al. · eLife · 2020 · 156 citations · Full text

Medicine, Immunology, Oncology +17

Activity of Adagrasib (MRTX849) in Brain Metastases: Preclinical Models and Clinical Data from Patients with KRASG12C-Mutant Non–Small Cell Lung Cancer

Joshua K. Sabari, Vamsidhar Velcheti, K. Shimizu et al. · Clinical Cancer Research · 2022 · 127 citations · Full text

Medicine, Oncology, Pharmacology +14

ONC201 (Dordaviprone) in Recurrent H3 K27M–Mutant Diffuse Midline Glioma

Isabel Arrillaga‐Romany, Sharon L. Gardner, Yazmín Odia et al. · Journal of Clinical Oncology · 2024 · 96 citations · Full text

Medicine, Oncology, Pharmacology +11

PD-1 inhibition has only limited clinical benefit in patients with recurrent high-grade glioma

Sylvia C. Kurz, Lais Cabrera, David Jeffrey Hastie et al. · Neurology · 2018 · 83 citations

Medicine, Oncology, Pharmacotherapy +17

Cell Surface Notch Ligand DLL3 is a Therapeutic Target in Isocitrate Dehydrogenase–mutant Glioma

Marissa Spino, Sylvia C. Kurz, Luis Chiriboga et al. · Clinical Cancer Research · 2018 · 82 citations · Full text

Medicine, Molecular Biology, Oncology +17